Is Eli Lilly on Track to Become the First Trillion-Dollar Biopharma Stock in the US?
Will Eli Lilly & Co. Reach a $1 Trillion Market Value? Evaluating Eli Lilly’s Potential to Enter the Rarefied Territory Eli Lilly & Co., the renowned American weight-loss drugmaker, is seen as a strong contender to become the first non-Magnificent Seven company to secure a remarkable $1 trillion market valuation. With an already soaring stock … Read more